These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33203894)

  • 1. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis.
    Zhuang Q; Li F; Liu J; Wang H; Tian Y; Zhang Z; Wang F; Zhao Z; Chen J; Wu H
    Lab Invest; 2021 Feb; 101(2):258-270. PubMed ID: 33203894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
    Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
    J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagic inhibitor ROC-325 ameliorates glomerulosclerosis and podocyte injury via inhibiting autophagic flux in experimental FSGS mice.
    Li J; Yang Y; Li L; Zheng S; Zhang H; Li C; Cai Y; Chen Y; Shi Q; Wang W; Luo J; Zhao X; Li R; Liang H; Chen Y; Zhang L; Liang X
    Eur J Pharmacol; 2024 Nov; 983():177007. PubMed ID: 39307335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear YAP localization as a key regulator of podocyte function.
    Bonse J; Wennmann DO; Kremerskothen J; Weide T; Michgehl U; Pavenstädt H; Vollenbröker B
    Cell Death Dis; 2018 Aug; 9(9):850. PubMed ID: 30154411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin.
    Li F; Mao X; Zhuang Q; Zhao Z; Zhang Z; Wu H
    Cell Death Dis; 2019 Mar; 10(3):241. PubMed ID: 30858353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ.
    Ester L; Cabrita I; Ventzke M; Kieckhöfer E; Christodoulou M; Mandel AM; Diefenhardt P; Fabretti F; Benzing T; Habbig S; Schermer B
    Hum Mol Genet; 2023 Nov; 32(22):3153-3165. PubMed ID: 37565816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
    Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
    Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
    Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
    Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
    Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
    J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
    Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
    J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling.
    Campbell KN; Wong JS; Gupta R; Asanuma K; Sudol M; He JC; Mundel P
    J Biol Chem; 2013 Jun; 288(24):17057-62. PubMed ID: 23667252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
    Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
    Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.